Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II/III trial of JP-1366 injection for bleeding peptic ulcer
CTR20253438Phase 3Active
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zastaprazan in Peptic ulcer disease (PUD), gastric ulcer, duodenal ulcer, sponsored by Livzon Pharmaceutical Group Inc.. Started Oct 2025; status: active.
02
Drugs
zastaprazan
03
Conditions
Peptic ulcer disease (PUD)gastric ulcerduodenal ulcer
Beyond the preview
Go deeper on CTR20253438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253438.